CooperVision’s Karen Walsh Appointed to Boards of IAPB and OGS

Published on March 13, 2026
ROCHESTER, N.Y.—CooperVision announced that Karen Walsh, senior director of global professional affairs, has been appointed to the boards of the International Agency for the Prevention of Blindness (IAPB) and Optometry Giving Sight. In making the announcement, the company said the appointments reinforce its longstanding commitment to advancing global eye health. “Access to vision care changes lives, families and communities,” Walsh said. “It is a privilege to serve on the boards of IAPB and Optometry Giving Sight, organizations focused on building sustainable eyecare solutions. I look forward to supporting their work to expand access to quality vision care worldwide.”
Continue reading on website
Other news

Congenital Hypertrophy the Most Common RPE Tumor, Research Finds

March 13, 2026
CHRPE, the most frequently diagnosed tumor in this study, is typically benign and asymptomatic but can cause vision problems if located near the macula. Photo: Julie Rodman, OD. Click image to enlarge. Congenital hypertrophy of the RPE (CHRPE) was the most common type of tumor found in a recent review of 926 participants with RPE cancers in a recent Philadelphia study; adeno

FDA Approves Johnson & Johnson’s TECNIS PureSee Intraocular Lens for U.S. Patients With Cataracts

March 13, 2026
JACKSONVILLE, Fla.—Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery in the United States. The TECNIS PureSee IOL delivers clarity of vision for patients, with 97 percent of them reporting no very bothersome visual disturbances, ac